Phase 3 N=813 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Adjusted Mean Change From Baseline in HbA1c at Week 24 — -0.34; -0.39; 0.03 HbA1c (%) — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=65 Pressure Ulcer Healing With Microcyn
Pressure Ulcer · Spinal Cord Injuries
Primary: Pressure Ulcer Size (Length x Width x Depth, cm^3) at Baseline — 10.13; 21.00 cm^3
N/A N=560 A Smoking Cessation Trial in HIV-infected Patients in South Africa
Smoking Cessation · HIV
Primary: Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO) — 11; 11 COppm
N/A N=350 Safe Kidney Care Cohort Study
Chronic Kidney Disease
Primary: The Discrete Incidence of Any of the Chronic Kidney Disease Patient Safety Indicators (CKD-PSIs) Endorsed by the Consensus Expert Panel — 108.7; 100.6; 38.3; 41.2 events…
Phase 2 N=107 An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects
Psoriasis Vulgaris
Primary: Adverse Drug Reactions (ADRs) — 2; 1; 1; 1 Number of adverse drug reactions
N/A N=3,187 Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)
Osteoporosis
Primary: Number of Participants With Treatment-Related Adverse Events — 137; 5 Participants
N/A N=22 Sentinel Node Detection in Clinical Early Stage Ovarian Cancer
Ovarian Cancer · Sentinel Node
Primary: Number of Patients (%) in Which Sentinel Node(s) Are Detected After Injection of Blue Dye and Tracer in the Ovarian Ligaments. — 21 participants
Phase 4 N=241 Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Chronic Hepatitis B
Primary: Percentage of Participants Achieving HBV DNA < 300 Copies/mL (51 IU/mL) at Week 52 (rITT Population) - — 91.0; 95.0; 91.9; 95.0 percentage of participants
N/A N=173 Comparing Force of Stream to Retrograde Fill Voiding Trial After Vaginal Apex Suspension
Vaginal Apical Prolapse
Primary: Number of Subjects Catheterized Within the Six-week Post-operative Period Following Surgical Repair of Prolapse, Among Those Discharged Without a Urinary Catheter. — 2…
N/A N=81 Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
Posttraumatic Stress Disorder · Depression
Primary: Clinician Administered PTSD Scale (CAPS-IV) — 75.9; 82.0; 54.4; 70.1 units on a scale
N/A N=40 Basal Insulin Strategies Before Surgery
Type2 Diabetes Mellitus
Primary: Pre-operative Fasting Blood Glucose, as Measured by Standardized Point of Care Capillary Blood Glucose (CBG) Device in the Pre-op Holding Area. — 144.0; 152.5 mg/dl
Phase 1 N=48 A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
Atrial Fibrillation
Primary: Subjects Achieving Normal Sinus Rhythm (NSR) in Patients With Paroxysmal AF — 0; 2; 0; 0 Participants
N/A N=9 Nutramax Joint Health Formulation Biochemical Response Study
Osteoarthritis, Knee
Primary: Serum Biomarkers — 130; 114; 109; 63 pg/ml
N/A N=116 Electric Warming Mattress to Prevent IPH During LSCS
Hypothermia · Anesthesia · Obstetric Anesthesia Problems
Primary: This Study Intends to Investigate Whether an Electric Warming Mattress Can Reduce Post-operative Hypothermia (Defined as Body Temperature of Less Than 36.0ºC) in…
N/A N=175 Long-Term Non-Interventional Latanoprost Study
Glaucoma · Ocular Hypertension
Primary: Change From Baseline to Last Available Observation in Best Corrected Visual Acuity (BCVA) (Snellen or Equivalent) — 0.25; -0.07; 0.01; 0.04 logMar — p=0.1126